Serum Institute gets nod to resume Oxford Covid-19 vaccine trial in India

The DCGI has also asked SII to submit the details of the medication used as per protocol for the management of the adverse events

from mint - News https://ift.tt/2GV38wb
https://ift.tt/eA8V8J